Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Viking Therapeutics Inc shares valued at $29,943 were purchased by Rouan Sarah Kathryn on Mar 31 ’25. At $24.15 per share, Rouan Sarah Kathryn acquired 1,240 shares. The insider’s holdings grew to 1,240 shares worth approximately $31843.2 following the completion of this transaction.
Also, Lian Brian sold 194,490 shares, netting a total of over 8,313,601 in proceeds. Following the sale of shares at $42.75 each, the insider now holds 2,366,570 shares.
Before that, Mancini Marianna had sold 54,215 shares from its account. In a trade valued at $2,317,599, the Chief Operating Officer traded Viking Therapeutics Inc shares for $42.75 each. Upon closing the transaction, the insider’s holdings decreased to 54,215 shares, worth approximately $9.61 million.
As published in their initiating research note from Scotiabank on February 13, 2025, Viking Therapeutics Inc [VKTX] has been a Sector outperform and the price target has been revised to $102. Analysts at Citigroup started covering the stock with ‘”a Neutral”‘ outlook in a report released in early February. As of December 02, 2024, Piper Sandler has initiated its “an Overweight” rating for VKTX. Earlier on November 22, 2024, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for VKTX stock.
Analyzing VKTX Stock Performance
During the last five days, there has been a drop of approximately -2.51%. Over the course of the year, Viking Therapeutics Inc shares have dropped approximately -36.18%. Shares of the company reached a 52-week high of $43.55 on 01/06/25 and a 52-week low of $23.27 on 03/31/25. A 50-day SMA is recorded $29.84, while a 200-day SMA reached $49.29.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 24.18, which, if violated, would cause prices to drop to 22.67. In the upper region, resistance lies at 26.47. The next price resistance is at 27.25. RSI (Relative Strength Index) is 41.19 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.04, which suggests the price will decrease in the coming days. Percent R is at 70.65%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Which companies own the most shares of Viking Therapeutics Inc (VKTX)?
On November 04, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $102.
